M84.561A: Pathological fracture in neoplastic disease, right tibia, initial encounter for fracture
M84.561A, pathological fracture in neoplastic disease, right tibia, initial encounter for fracture, is listed as a covered diagnosis in 3 Medicare billing and coding articles that apply to 70 HCPCS Level II codes, including J0897 (Injection, denosumab, 1 mg), Q5136 (Injection, denosumab-bbdz (jubbonti/wyost), biosimilar, 1 mg), Q5157 (Injection, denosumab-bmwo (stoboclo/osenvelt), biosimilar…). 47 of these codes have a 2026 DMEPOS fee schedule amount; L1844 pays $1,865.51 to $2,436.24 depending on the state. The articles come from 2 Medicare contractors. A listed diagnosis supports medical necessity only; coverage still depends on the LCD's criteria and on documentation in the medical record.
HCPCS Level II codes with M84.561A as a covered diagnosis
| Code | Description | Medicare coverage | DMEPOS fee 2026 (state range) | Articles listing it |
|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Carrier judgment | — | 1 |
| Q5136 | Injection, denosumab-bbdz (jubbonti/wyost), biosimilar, 1 mg | Carrier judgment | — | 1 |
| Q5157 | Injection, denosumab-bmwo (stoboclo/osenvelt), biosimilar, 1 mg | Carrier judgment | — | 1 |
| Q5158 | Injection, denosumab-bnht (bomyntra/conexxence), biosimilar, 1 mg | Carrier judgment | — | 1 |
| Q5159 | Injection, denosumab-dssb (ospomyv/xbryk), biosimilar, 1 mg | Carrier judgment | — | 1 |
| Q5162 | Injection, denosumab-nxxp (bildyos/bilprevda), biosimilar, 1 mg | Carrier judgment | — | 1 |
| Q5165 | Injection, denosumab-mobz (oziltus), biosimilar, 1 mg | Carrier judgment | — | 1 |
| Q5166 | Injection, denosumab-desu (osvyrti/jubereq), biosimilar, 1 mg | Carrier judgment | — | 1 |
| Q5167 | Injection, denosumab-qbde (enoby/xtrenbo), biosimilar, 1 mg | Carrier judgment | — | 1 |
| Q5171 | Injection, denosumab-mobz (boncresa), biosimilar, 1 mg | Carrier judgment | — | 1 |
| L1844 | Knee orthosis, single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, custom fabricated | Carrier judgment | $1,865.51–$2,436.24 | 1 |
| L1860 | Knee orthosis, modification of supracondylar prosthetic socket, custom fabricated (sk) | Carrier judgment | $1,233.07–$1,985.94 | 1 |
| L1846 | Knee orthosis, double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, custom fabricated | Carrier judgment | $1,283.72–$1,960.17 | 1 |
| L1834 | Knee orthosis, without knee joint, rigid, custom fabricated | Carrier judgment | $892.02–$1,808.36 | 1 |
| L1832 | Knee orthosis, adjustable knee joints (unicentric or polycentric), positional orthosis, rigid support, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | Carrier judgment | $698.63–$1,618.03 | 1 |
| L1840 | Knee orthosis, derotation, medial-lateral, anterior cruciate ligament, custom fabricated | Carrier judgment | $1,056.60–$1,606.15 | 1 |
| L1843 | Knee orthosis, single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | Carrier judgment | $1,076.26–$1,183.90 | 1 |
| L1845 | Knee orthosis, double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | Carrier judgment | $939.24–$1,180.51 | 1 |
| L1833 | Knee orthosis, adjustable knee joints (unicentric or polycentric), positional orthosis, rigid support, prefabricated, off-the shelf | Carrier judgment | $455.16–$1,087.16 | 1 |
| L1851 | Knee orthosis (ko), single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf | Carrier judgment | $600.78–$959.09 | 1 |
| L1852 | Knee orthosis (ko), double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf | Carrier judgment | $573.13–$940.49 | 1 |
| L2330 | Addition to lower extremity, lacer molded to patient model, for custom fabricated orthosis only | Carrier judgment | $429.42–$904.14 | 1 |
| L1847 | Knee orthosis, double upright with adjustable joint, with inflatable air support chamber(s), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | Carrier judgment | $689.92–$827.89 | 1 |
| L1848 | Knee orthosis, double upright with adjustable joint, with inflatable air support chamber(s), prefabricated, off-the-shelf | Carrier judgment | $689.92–$827.89 | 1 |
| L1850 | Knee orthosis, swedish type, prefabricated, off-the-shelf | Carrier judgment | $205.78–$408.53 | 1 |
45 more codes are listed. See every code with payment by region in Caduvo.
Medicare policy articles listing M84.561A
- A52399: Billing and Coding: Denosumab (Prolia®, Xgeva®, Jubbonti®) and biosimilars (Wellpoint Federal (MAC - Part A, MAC - Part B); 10 Level II codes)
- A52465: Knee Orthoses - Policy Article (CGS Administrators, LLC (DME MAC) Noridian Healthcare Solutions, LLC (DME MAC); 53 Level II codes). LCD with the same title: L33318
- A57311: Billing and Coding: Physical Therapy - Home Health (CGS Administrators, LLC (HHH MAC); 7 Level II codes). LCD with the same title: L33942
A diagnosis listed as covered in a billing and coding article supports medical necessity for the article's codes; it does not guarantee payment. Coverage depends on the LCD's criteria, the contractor's jurisdiction and documentation in the medical record.
Other M84 diagnoses (Disorder of continuity of bone)
- M84.562A — Pathological fracture in neoplastic disease, left tibia, initial…
- M84.563A — Pathological fracture in neoplastic disease, right fibula, initial…
- M84.564A — Pathological fracture in neoplastic disease, left fibula, initial…
- M84.550A — Pathological fracture in neoplastic disease, pelvis, initial…
- M84.551A — Pathological fracture in neoplastic disease, right femur, initial…
- M84.552A — Pathological fracture in neoplastic disease, left femur, initial…
- M84.58XA — Pathological fracture in neoplastic disease, other specified site…
- M84.350A — Stress fracture, pelvis, initial encounter for fracture
- M84.351A — Stress fracture, right femur, initial encounter for fracture
- M84.352A — Stress fracture, left femur, initial encounter for fracture
- M84.451A — Pathological fracture, right femur, initial encounter for fracture
- M84.452A — Pathological fracture, left femur, initial encounter for fracture
- M84.454A — Pathological fracture, pelvis, initial encounter for fracture
- M84.651A — Pathological fracture in other disease, right femur, initial…
- M84.652A — Pathological fracture in other disease, left femur, initial…
- M84.68XA — Pathological fracture in other disease, other site, initial…
Frequently asked questions
Does Medicare cover M84.561A (Pathological fracture in neoplastic disease, right tibia…)?
Medicare covers items and services, not diagnoses. 3 Medicare billing and coding articles list M84.561A as a covered diagnosis for 70 HCPCS Level II codes: the diagnosis can support medical necessity for those codes, but payment still depends on the LCD's coverage criteria and the medical record.
Which HCPCS codes can be billed with ICD-10 M84.561A?
The Level II codes from the policies most specific to this diagnosis are J0897 (Injection, denosumab, 1 mg, 1 article); Q5136 (Injection, denosumab-bbdz (jubbonti/wyost), biosimilar, 1 mg, 1 article); Q5157 (Injection, denosumab-bmwo (stoboclo/osenvelt), biosimilar…, 1 article); Q5158 (Injection, denosumab-bnht (bomyntra/conexxence)…, 1 article); Q5159 (Injection, denosumab-dssb (ospomyv/xbryk), biosimilar, 1 mg, 1 article). Code choice depends on the item supplied; check each code's descriptor.
What does Medicare pay for equipment billed with M84.561A?
Under the 2026 DMEPOS fee schedule (non-rural state fees): L1844 $1,865.51 to $2,436.24; L1860 $1,233.07 to $1,985.94; L1846 $1,283.72 to $1,960.17; L1834 $892.02 to $1,808.36. Medicare pays 80% of the allowed amount after the Part B deductible.
Which Medicare policy articles list M84.561A?
A52399 (Billing and Coding: Denosumab (Prolia®, Xgeva®, Jubbonti®) and biosimilars); A52465 (Knee Orthoses - Policy Article); A57311 (Billing and Coding: Physical Therapy - Home Health).
What is ICD-10-CM code M84.561A?
M84.561A is the ICD-10-CM code for pathological fracture in neoplastic disease, right tibia, initial encounter for fracture, in category M84 (Disorder of continuity of bone), chapter 13: Diseases of the musculoskeletal system and connective tissue.
Next steps
- Run a reimbursement report for a device billed under J0897
- Watch J0897 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J0897
Sources: CMS Medicare Coverage Database billing and coding articles (covered ICD-10 code lists and HCPCS links); ICD-10-CM FY2026; CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule 2026 (non-rural state fees). Not billing or legal advice.
Chapter 13: Diseases of the musculoskeletal system and connective tissue · All diagnoses · HCPCS lookup